Achillion to Present at the Wells Fargo 2013 Healthcare Conference

Achillion to Present at the Wells Fargo 2013 Healthcare Conference

NEW HAVEN, Conn., June 12, 2013 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals,
Inc. (Nasdaq:ACHN) announced today that Milind Deshpande, President and Chief
Executive Officer of Achillion, and members of the senior management team will
present a corporate update and participate on a HCV Panel at the Wells Fargo
2013 Healthcare Conference on Tuesday, June 18, 2013 at 8:50 a.m. and 10:00
a.m. EDT, respectively, at the Intercontinental Hotel in Boston, MA.

The live audio broadcasts and the subsequent archived webcasts of the
Company's presentations will be available on the Company's website,
http://www.achillion.com, under the "News Center" section. The audio recording
will be archived for 30 days following the live presentation. Please connect
to Achillion's website several minutes prior to the start of the presentation
to ensure adequate time for any software downloads that may be necessary.

About Achillion Pharmaceuticals

Achillion is an innovative pharmaceutical company dedicated to bringing
important new treatments to patients with infectious disease. Achillion's
discovery, clinical development, and commercial teams have advanced multiple
novel product candidates with proven mechanisms of action into studies and
toward the market. Achillion is focused on solutions for the most challenging
problems in infectious disease including HCV and resistant bacterial
infections. For more information on Achillion Pharmaceuticals, please visit
www.achillion.com or call 1-203-624-7000.

CONTACT: Company Contact:
         Glenn Schulman
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 752-5510
         gschulman@achillion.com
        
         Investors:
         Mary Kay Fenton
         Achillion Pharmaceuticals, Inc.
         Tel. (203) 624-7000
         mfenton@achillion.com

Achillion Pharmaceuticals logo